BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 27935998)

  • 41. Cysteinyl leukotriene receptor (CysLT) antagonists decrease pentylenetetrazol-induced seizures and blood-brain barrier dysfunction.
    Lenz QF; Arroyo DS; Temp FR; Poersch AB; Masson CJ; Jesse AC; Marafiga JR; Reschke CR; Iribarren P; Mello CF
    Neuroscience; 2014 Sep; 277():859-71. PubMed ID: 25090924
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tumor necrosis factor-alpha enhances mRNA expression and secretion of interleukin-6 in cultured human airway smooth muscle cells.
    McKay S; Hirst SJ; Haas MB; de Jongste JC; Hoogsteden HC; Saxena PR; Sharma HS
    Am J Respir Cell Mol Biol; 2000 Jul; 23(1):103-11. PubMed ID: 10873159
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Leukotriene C4 induces bronchoconstriction and airway vascular hyperpermeability via the cysteinyl leukotriene receptor 2 in S-hexyl glutathione-treated guinea pigs.
    Yonetomi Y; Sekioka T; Kadode M; Kitamine T; Kamiya A; Matsumura N; Fujita M; Kawabata K
    Eur J Pharmacol; 2015 May; 754():98-104. PubMed ID: 25704617
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of the leukotriene receptor antagonist zafirlukast on neurokinin A-induced bronchoconstriction in patients with asthma--A comparison with leukotriene D4 induced broncoconstriction.
    Schelfhout V; Van De Velde V; Pauwels R; Joos G
    Pulm Pharmacol Ther; 2008; 21(2):276-84. PubMed ID: 17611132
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The inflammatory mediator leukotriene D4 triggers a rapid reorganisation of the actin cytoskeleton in human intestinal epithelial cells.
    Massoumi R; Sjölander A
    Eur J Cell Biol; 1998 Jul; 76(3):185-91. PubMed ID: 9716265
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of the pharmacological activity of the pure cysteinyl-leukotriene receptor antagonists CGP 45715A (iralukast) and CGP 57698 in human airways.
    Capra V; Ravasi S; Bolla M; Viappiani S; Pagliardini S; Belloni PA; Mezzetti M; Folco GC; Nicosia S; Rovati GE
    Adv Exp Med Biol; 1999; 469():313-8. PubMed ID: 10667347
    [No Abstract]   [Full Text] [Related]  

  • 47. Activation of human bronchial epithelial cells by inflammatory cytokines IL-27 and TNF-alpha: implications for immunopathophysiology of airway inflammation.
    Cao J; Wong CK; Yin Y; Lam CW
    J Cell Physiol; 2010 Jun; 223(3):788-97. PubMed ID: 20301193
    [TBL] [Abstract][Full Text] [Related]  

  • 48. ZLJ-6, a novel COX/5-LOX inhibitor, attenuates TNF-α-induced endothelial E-selectin, ICAM-1 and VCAM-1 expression and monocyte-endothelial interactions via a COX/5-LOX-independent mechanism.
    Chen L; Zhao Q; Wang XL; You R; Zhang YH; Ji H; Lai YS
    Vascul Pharmacol; 2011; 55(5-6):135-42. PubMed ID: 21777697
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Proinflammatory cytokine-induced and chemical mediator-induced IL-8 expression in human bronchial epithelial cells through p38 mitogen-activated protein kinase-dependent pathway.
    Matsumoto K; Hashimoto S; Gon Y; Nakayama T; Horie T
    J Allergy Clin Immunol; 1998 Jun; 101(6 Pt 1):825-31. PubMed ID: 9648711
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function.
    Kain V; Ingle KA; Colas RA; Dalli J; Prabhu SD; Serhan CN; Joshi M; Halade GV
    J Mol Cell Cardiol; 2015 Jul; 84():24-35. PubMed ID: 25870158
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 5-Lipoxygenase mediates RANKL-induced osteoclast formation via the cysteinyl leukotriene receptor 1.
    Lee JM; Park H; Noh AL; Kang JH; Chen L; Zheng T; Lee J; Ji SY; Jang CY; Shin CS; Ha H; Lee ZH; Park HY; Lee DS; Yim M
    J Immunol; 2012 Dec; 189(11):5284-92. PubMed ID: 23109727
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Leukotriene D4-induced activation of smooth-muscle cells from human bronchi is partly Ca2+-independent.
    Accomazzo MR; Rovati GE; Viganò T; Hernandez A; Bonazzi A; Bolla M; Fumagalli F; Viappiani S; Galbiati E; Ravasi S; Albertoni C; Di Luca M; Caputi A; Zannini P; Chiesa G; Villa AM; Doglia SM; Folco G; Nicosia S
    Am J Respir Crit Care Med; 2001 Jan; 163(1):266-72. PubMed ID: 11208655
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of specialized pro-resolving lipid mediators in the regulation of vascular tone and inflammation in human saphenous vein.
    Celik Z; Ozen G; Sunar S; Turkyilmaz S; Turkyilmaz G; Kavala AA; Teskin O; Dogan BSU; Topal G
    Prostaglandins Other Lipid Mediat; 2023 Dec; 169():106786. PubMed ID: 37806440
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Studies of receptors and modulatory mechanisms in functional responses to cysteinyl-leukotrienes in smooth muscle.
    Bäck M
    Acta Physiol Scand Suppl; 2002 Feb; 648():1-55. PubMed ID: 11913222
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regulation of rotenone-induced microglial activation by 5-lipoxygenase and cysteinyl leukotriene receptor 1.
    Zhang XY; Chen L; Yang Y; Xu DM; Zhang SR; Li CT; Zheng W; Yu SY; Wei EQ; Zhang LH
    Brain Res; 2014 Jul; 1572():59-71. PubMed ID: 24858057
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Eicosapentaenoic acid and docosahexaenoic acid modulate mitogen-activated protein kinase activity in endothelium.
    Xue H; Wan M; Song D; Li Y; Li J
    Vascul Pharmacol; 2006 Jun; 44(6):434-9. PubMed ID: 16616699
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anti-cancer and analgesic effects of resolvin D2 in oral squamous cell carcinoma.
    Ye Y; Scheff NN; Bernabé D; Salvo E; Ono K; Liu C; Veeramachaneni R; Viet CT; Viet DT; Dolan JC; Schmidt BL
    Neuropharmacology; 2018 Sep; 139():182-193. PubMed ID: 30009833
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Leukotriene receptor antagonist as a novel tocolytic in an in vitro model of human uterine contractility.
    Corriveau S; Rousseau É; Blouin S; Pasquier JC
    Eur J Obstet Gynecol Reprod Biol; 2014 Jun; 177():77-83. PubMed ID: 24735655
    [TBL] [Abstract][Full Text] [Related]  

  • 59. SB 239063, a potent p38 MAP kinase inhibitor, reduces inflammatory cytokine production, airways eosinophil infiltration, and persistence.
    Underwood DC; Osborn RR; Kotzer CJ; Adams JL; Lee JC; Webb EF; Carpenter DC; Bochnowicz S; Thomas HC; Hay DW; Griswold DE
    J Pharmacol Exp Ther; 2000 Apr; 293(1):281-8. PubMed ID: 10734180
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Montelukast inhibits inflammatory responses in small airways of the Guinea-pig.
    Harrison S; Gatti R; Baraldo S; Oliani KL; Andre E; Trevisani M; Gazzieri D; Saetta M; Geppetti P
    Pulm Pharmacol Ther; 2008; 21(2):317-23. PubMed ID: 17905619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.